- 全部删除
您的购物车当前为空
PST3.1a是一种选择性的Mannoside acetyl glucosaminyltransferase 5(MGAT5)抑制剂,可用于研究多形性胶质母细胞瘤(GBM)。PST3.1a抑制与doublecortin(DCX)相关的TGF-βR和FAK信号,增加OLIG2表达,抑制GBM启动细胞(GIC)的侵袭和增殖。


为众多的药物研发团队赋能,
让新药发现更简单!
PST3.1a是一种选择性的Mannoside acetyl glucosaminyltransferase 5(MGAT5)抑制剂,可用于研究多形性胶质母细胞瘤(GBM)。PST3.1a抑制与doublecortin(DCX)相关的TGF-βR和FAK信号,增加OLIG2表达,抑制GBM启动细胞(GIC)的侵袭和增殖。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,380 | 待询 | |
| 5 mg | ¥ 5,930 | 待询 | |
| 10 mg | ¥ 8,460 | 10-14周 | |
| 25 mg | ¥ 14,600 | 待询 | |
| 50 mg | ¥ 26,200 | 10-14周 |
PST3.1a 相关产品
| 产品描述 | PST3.1a is a selective inhibitor of Mannoside acetyl glucosaminyltransferase 5 (MGAT5), used for studying glioblastoma multiforme (GBM). PST3.1a inhibits TGF-βR and FAK signalling associated with doublecortin (DCX), increases OLIG2 expression, and suppresses the invasion and proliferation of GBM initiator cells (GICs). |
| 靶点活性 | MGAT5:2 μM |
| 别名 | PST3 1a |
| 分子量 | 544.57 |
| 分子式 | C32H33O6P |
| CAS No. | 1096144-06-7 |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容